References
- Brune K, Nürnberg B, Szelenyi I, Vergin H. Enterohepatic circulation of some anti-inflammatory drugs as possible cause of intestinal ulcerations. MTP-press, London 1986, in press
- Collier DStJ, Pain JA. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 1984; 26: 359–63
- Somerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986; 1: 462–4
- Brune K, Lanz R. Pharmacokinetics of non-steroidal anti-inflammatory drugs. Handbook of inflammation., IL Bonta, MA Bray, MJ Parnham. Elsevier, Amsterdam 1985; 5: 413–49
- Walt R, Katschinski B, Logan R, Ashley J, Langman M. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet 1986; 1: 489–92
- Langman M JS, Morgan L, Worrall A. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br Med J 1985; 290: 347–9
- Duggan D E., Hooke K F., Noll R M., Kwan KC. Enterohepatic circulation of indomethacin and its role in intestinal irritation. Biochem Pharmacol 1975; 25: 1749–54
- Kwan K C., Breault G O., Umbenhauer E R., Mc Mahon F G., Duggan DE. Kinetics of indomethacin absorption, elimination and enterohepatic circulation in man. J Pharmac Biopharm 1976; 4: 255–80
- Yesair A D., Callahan M, Remington L, Kensler CJ. Role of the entero-hepatic cycle of indomethacin on its metabolism, distribution in tissues and its excretion by rats, dogs and monkeys. Biochem Pharmacol 1970; 19: 1579–90
- Robert A. Duodenal ulcers in the rat: production and prevention. Peptic ulcer., CJ Pfeiffer. Munksgaard, Copenhagen 1971; 21–33
- Lockwood G F., Wagner JG. High-performance liquid chromatographic determination of ibuprofen and its major metabolites in biological fluids. J Chromatogr 1982; 232: 335–43
- Nürnberg B, Brune K. Analyse der biliaren Elimination eines nichtsteroidalen Antirheumatikums (Diflunisal) bei Mensch und Hund. Akt Rheumatol 1986; 11: 116–20
- Dubinsky B, Gebre-Mariam S, Capetola R J., Rosenthale ME. The analgesic drugs: human therapeutic correlates of their potency in laboratory animal models of hyperalgesia. Agents Actions 1987; 20, in press
- Shen T Y., Winter Ch A. Chemical and biological studies on indomethacin, sulindac and their analogs. Adv Drug Res 1977; 12: 89–245
- Mills R FN, Adams S S., Cliffe E E., Dickinson W, Nicholson JS. The metabolism of ibuprofen. Xenobiotica 1973; 3: 589–98
- Lin J H., Yeh K C., Duggan DE. Effect of enterohepatic circulation on the pharmacokinetics of diflunisal in rats. Drug Metab Dispos 1985; 13: 321–6
- Stierlin H, Faigle JW., II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile. Xenobiotica 1979; 9: 611–21
- Paulus HE. FDA Arthritis Advisory Committee Meeting: Postmarketing surveillance of non-steroidal anti-inflammatory drugs. Arth Rheum 1985; 28: 1168–9
- Dujovne C A., Pitterman A, Vincek W C., Dobrinska M R., Davies R O., Duggan DE. Enterohepatic circulation of sulindac and metabolites. Clin Pharmacol Ther 1983; 33: 172–7
- Levy M, Kaufman M, Shapiro DW. Major upper gastrointestinal bleeding in relation to aspirin and acetaminophen use. Poster 1656. III. World Conference in Clinical Pharmacology and Therapeutics. Stockholm 1986
- Brune K. How aspirin might work a pharmacokinetic approach. Agents Actions 1974; 4: 230